The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H
- PMID: 8620935
- DOI: 10.1007/BF01919535
The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H
Abstract
Few inhibitors of the RNase H function associated with the HIV-1 reverse transcriptase have been discovered to date. We observed that three novenamines, U-34445, U-35122, and U-35401, are specific inhibitors of the HIV-1 RT RNase H function. All three compounds are strong amphiphiles and contain one ionizable group. Hence, a priori, in aqueous solutions the inhibitors might exist in at least four different physical states, namely protonated monomers, ionized monomers, protonated micelles, and ionized micelles. The three inhibitors all yielded anomalous dose-response curves, indicating that the four molecular species have different inhibitory potentials. In order to identify the inhibitory species, the amphiphilic properties of these compounds were studied. It was established that in alkaline solutions, around pH 8, all compounds are ionized and form micelles at concentrations above their CMC. Both the protonated and the ionized forms of these molecules form stable insoluble monomolecular layers at the air/water interface. The anomalies of the dose-response curves can be resolved by taking into account the fact that, in solution, the relative proportion of these molecules in each physical state depends on the pH and on their analytical concentration. Thus interpreted, the results indicate that RNase H is inhibited only by the ionized micellar form of these compounds and not by their monomeric form. Around their pKa (approximately pH 5), the three compounds reproducibly form uniformly sized, self-emulsified colloidal particles that may be used as an efficient drug delivery system.
Similar articles
-
Novenamines as inhibitors of two independent enzymes during DNA replication in a toluenized Escherichia coli cell system.Biochem Pharmacol. 1996 May 17;51(10):1373-8. doi: 10.1016/0006-2952(96)00061-5. Biochem Pharmacol. 1996. PMID: 8787554
-
5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.Eur J Med Chem. 2018 Jul 15;155:714-724. doi: 10.1016/j.ejmech.2018.06.036. Epub 2018 Jun 18. Eur J Med Chem. 2018. PMID: 29940462
-
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx065. Pathog Dis. 2017. PMID: 28637198
-
Uncovering the complexities of retroviral ribonuclease H reveals its potential as a therapeutic target.AIDS Rev. 2002 Oct-Dec;4(4):183-94. AIDS Rev. 2002. PMID: 12555693 Review.
-
Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.Antivir Chem Chemother. 2014 Jan 29;23(4):129-44. doi: 10.3851/IMP2690. Antivir Chem Chemother. 2014. PMID: 24150519 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources